LOGC
Charles Schwab’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,498
| Closed | -$27K | – | 3648 |
|
|
2021
Q4 | $27K | Hold |
11,498
| – | – | ﹤0.01% | 3562 |
|
|
2021
Q3 | $53K | Buy |
+11,498
| New | +$53K | ﹤0.01% | 3443 |
|
|
2021
Q2 | – | Sell |
-40,646
| Closed | -$296K | – | 3585 |
|
|
2021
Q1 | $296K | Buy |
40,646
+6,448
| +19% | +$47K | ﹤0.01% | 3249 |
|
|
2020
Q4 | $261K | Buy |
34,198
+8,278
| +32% | +$63.2K | ﹤0.01% | 3212 |
|
|
2020
Q3 | $236K | Hold |
25,920
| – | – | ﹤0.01% | 3127 |
|
|
2020
Q2 | $220K | Buy |
25,920
+7,751
| +43% | +$65.8K | ﹤0.01% | 3151 |
|
|
2020
Q1 | $90K | Hold |
18,169
| – | – | ﹤0.01% | 3114 |
|
|
2019
Q4 | $131K | Hold |
18,169
| – | – | ﹤0.01% | 3080 |
|
|
2019
Q3 | $197K | Sell |
18,169
-4,315
| -19% | -$46.8K | ﹤0.01% | 3038 |
|
|
2019
Q2 | $293K | Buy |
22,484
+1,969
| +10% | +$25.7K | ﹤0.01% | 3017 |
|
|
2019
Q1 | $203K | Buy |
20,515
+4,315
| +27% | +$42.7K | ﹤0.01% | 3019 |
|
|
2018
Q4 | $169K | Buy |
+16,200
| New | +$169K | ﹤0.01% | 3040 |
|